[Pharmaceutical development aimed at improving safety for children].
The safety of paediatric drugs should be improved so that the number of child deaths due to the misuse of different kinds of medication can be decreased. Formulations, excipients and containers are the major areas that should be optimised in the pharmaceutical development of a paediatric drug. Today, Afssaps (Agence française de sécurité sanitaire des produits de santé) and the European regulations play a major role in promoting paediatric medications.
Andrieu
Véronique
V
Laboratoire de Pharmacie Galénique Industrielle, Faculté de Pharmacie, Marseille, France. veronique.andrieu@pharmacie.univ-mrs.fr
Reynier
Jean-Pierre
JP
D002626:Chemistry, Pharmaceutical; D002648:Child; D004349:Drug Packaging; D064420:Drug-Related Side Effects and Adverse Reactions; D005079:Excipients; D005602:France / Q000453:epidemiology; D006801:Humans; D011041:Poisoning / Q000453:epidemiology; D012449:Safety
D005079:Excipients